Tumor-induced inflammation has been found to contribute to muscle depletion and dysregulation of skeletal muscle physiology with pro-inflammatory cytokines such as interleukins and TNF-α, as causative mediators (30–33). This evidence concerns the gene TNF and neoplasm.